Literature DB >> 3511702

Vaginal colonization with Escherichia coli in healthy women. Determination of relative risks by quantitative culture and multivariate statistical analysis.

A W Chow, R Percival-Smith, K H Bartlett, A M Goldring, B J Morrison.   

Abstract

The rate of vaginal colonization with Escherichia coli in 495 healthy women was 12% in a prospective study with use of selective media and semiquantitative culture techniques. Computer-assisted multivariate analysis revealed that vaginal E. coli was significantly associated with the menstrual phase of the cycle, prior use of antibiotics, use of diaphragm or cervical cap for contraception, history of previous urinary tract infection, and coisolation of Staphylococcus aureus that was positive for the toxic shock syndrome toxin-1 (p less than 0.05, multiple stepwise logistic regression analysis). No significant association was observed with tampon use or brand, other contraceptive methods, sexual activity, genital symptoms, recent vaginal infection, or other personal habits. Quantitative cultures obtained sequentially throughout the menstrual cycle in 12 unselected women confirmed higher E. coli counts in menstrual or midcycle samples compared to paired premenstrual specimens (p less than 0.05, Wilcoxon paired rank sign test). These data emphasize the hormonal and other host determinants in vaginal colonization by E. coli and may explain the high rate of vaginal E. coli (64%), in addition to toxicogenic S. aureus, in acute toxic shock syndrome and the higher incidence of urinary tract infection in women with diaphragm or cervical cap for contraception compared to other contraceptive methods.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3511702     DOI: 10.1016/0002-9378(86)90406-0

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  High incidence of Crohn's disease in pre-menopausal women: Escherichia coli may be contributing.

Authors:  A M El-Tawil
Journal:  Int J Colorectal Dis       Date:  2004-04-15       Impact factor: 2.571

2.  The human vagina: normal flora considered as an in situ tissue-associated, adherent biofilm.

Authors:  P A Domingue; K Sadhu; J W Costerton; K Bartlett; A W Chow
Journal:  Genitourin Med       Date:  1991-06

3.  Bacterial vaginosis: culture- and PCR-based characterizations of a complex polymicrobial disease's pathobiology.

Authors:  Apoorv Kalra; Cristina T Palcu; Jack D Sobel; R A Akins
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

Review 4.  Blood Groups in Infection and Host Susceptibility.

Authors:  Laura Cooling
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

Review 5.  Models matter: the search for an effective Staphylococcus aureus vaccine.

Authors:  Wilmara Salgado-Pabón; Patrick M Schlievert
Journal:  Nat Rev Microbiol       Date:  2014-07-07       Impact factor: 60.633

Review 6.  Staphylococcal and streptococcal superantigen exotoxins.

Authors:  Adam R Spaulding; Wilmara Salgado-Pabón; Petra L Kohler; Alexander R Horswill; Donald Y M Leung; Patrick M Schlievert
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

7.  Site-specific prevalence and cell densities of selected microbes in the lower reproductive tract of menstruating tampon users.

Authors:  Anne E Hochwalt; Ronald W Berg; Sandy J Meyer; Rachelle Eusebio
Journal:  Infect Dis Obstet Gynecol       Date:  2002

8.  Clinical safety-in-use study of a new tampon design.

Authors:  Stacey E Shehin; Michaelle B Jones; Anne E Hochwalt; Frank C Sarbaugh; Stephen Nunn
Journal:  Infect Dis Obstet Gynecol       Date:  2003

9.  Changes in the vaginal microbiota following antibiotic treatment for Mycoplasma genitalium, Chlamydia trachomatis and bacterial vaginosis.

Authors:  Peter Ahrens; Lee O'Brien Andersen; Berit Lilje; Thor Bech Johannesen; Ebba Gomez Dahl; Sharmin Baig; Jørgen Skov Jensen; Lars Falk
Journal:  PLoS One       Date:  2020-07-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.